Atara Biotherapeutics, Inc 10-K for FY2024
Atara Biotherapeutics, Inc. (ATRA)
10-K
2025-03-07
For: 2024-12-31
View Original
Added on
April 11, 2026
About this 10-K
Atara Biotherapeutics, Inc filed this 10-K on March 7, 2025, covering the fiscal year ended December 31, 2024 (FY2024).
Headline figures
Fiscal year ended December 31, 2024, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $128.94M
- up 1404.0% from $8.57M a year earlier
- Net loss
- $85.4M
- compared with a net loss of $276.13M a year earlier
- Diluted EPS
- -$11.41
- compared with -$65.19 a year earlier